SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
20621074
Source:
http://linkedlifedata.com/resource/pubmed/id/20621074
Search
Subject
(
52
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0003280
,
umls-concept:C0005516
,
umls-concept:C0043031
,
umls-concept:C0150369
,
umls-concept:C0442027
,
umls-concept:C0950248
,
umls-concept:C1280500
pubmed:issue
13-14
pubmed:dateCreated
2010-8-31
pubmed:abstractText
To determine whether PIVKA-II can serve as a monitoring marker of warfarin treatment.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0133660
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anticoagulants
,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers
,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Precursors
,
http://linkedlifedata.com/resource/pubmed/chemical/Prothrombin
,
http://linkedlifedata.com/resource/pubmed/chemical/Warfarin
,
http://linkedlifedata.com/resource/pubmed/chemical/acarboxyprothrombin
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1873-2933
pubmed:author
pubmed-author:ChiHyun-SookHS
,
pubmed-author:ChunSailS
,
pubmed-author:ChungHee-JungHJ
,
pubmed-author:JangSeongsooS
,
pubmed-author:KimSollipS
,
pubmed-author:LeeWoochangW
,
pubmed-author:MinWon-KiWK
,
pubmed-author:ParkChan-JeoungCJ
pubmed:copyrightInfo
Copyright (c) 2010 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
43
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1177-9
pubmed:meshHeading
pubmed-meshheading:20621074-Aged
,
pubmed-meshheading:20621074-Anticoagulants
,
pubmed-meshheading:20621074-Biological Markers
,
pubmed-meshheading:20621074-Drug Monitoring
,
pubmed-meshheading:20621074-Humans
,
pubmed-meshheading:20621074-International Normalized Ratio
,
pubmed-meshheading:20621074-Middle Aged
,
pubmed-meshheading:20621074-Protein Precursors
,
pubmed-meshheading:20621074-Prothrombin
,
pubmed-meshheading:20621074-Warfarin
pubmed:year
2010
pubmed:articleTitle
PIVKA-II is a candidate marker for monitoring the effects of the oral anticoagulant warfarin.
pubmed:affiliation
Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul 138-736, Korea.
pubmed:publicationType
Journal Article
,
Evaluation Studies